Stroke-like brain damage reduced by omega-3 acids in preclinical model

Researchers from Columbia University Medical Center (NY, USA) have treated a neonatal mouse model of hypoxic-ischemic brain injury utilizing triglyceride emulsions of docosahexaenoic acid (tri-DHA). Results indicate that treatment with tri-DHA may significantly reduce oxidative damage and improve neurological outcomes following these types of brain injury.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please Login or Register to view this area.

cerebrovascular disease ischemic neuropathology stroke